Merifin Capital

Merifin Capital is a private equity and venture capital firm in Belgium that focuses on traditional and alternative asset classes. Founded 2000 in Brussels Hoofdstedelijk Gewest, Belgium, it invests in early stage ventures and late stage ventures. Its portfolio companies include F2G, DoveConviene, Flayr, Plastic Logic Germany, Metara, DanioLabs, and immatics biotechnologies. As of March 2020, Merifin Capital has made 12 investments. Their most recent investment was on June 20, 2016, when F2G raised $60M. Merifin Capital has had three exits, the most notable of which include immatics biotechnologies, Cyclacel Pharmaceuticals, and DanioLabs.

Merifin Capital is a private equity and venture capital firmventure capital firm in Belgium that focuses on traditional and alternative asset classes. Founded 2000 in Brussels Hoofdstedelijk Gewest, Belgium, it invests in early stage ventures and late stage ventures. Its portfolio companies include F2G, DoveConviene, Flayr, Plastic Logic Germany, Metara, DanioLabs, and immatics biotechnologies. As of March 2020, Merifin Capital has made 12 investments. Their most recent investment was on June 20, 2016, when F2G raised $60M. Merifin Capital has had three exits, the most notable of which include immatics biotechnologies, Cyclacel Pharmaceuticals, and DanioLabs.

Merifin Capital is a private equity and venture capital firm in Belgium that focuses on traditional and alternative asset classes. Founded 2000 in Brussels Hoofdstedelijk Gewest, Belgium, it invests in early stage ventures and late stage ventures. Its portfolio companies include F2G, DoveConviene, FlayrFlayr, Plastic Logic Germany, Metara, DanioLabs, and immatics biotechnologies. As of March 2020, Merifin Capital has made 12 investments. Their most recent investment was on June 20, 2016, when F2G raised $60M. Merifin Capital has had three exits, the most notable of which include immatics biotechnologies, Cyclacel Pharmaceuticals, and DanioLabs.

Merifin Capital is a private equity and venture capital firm in Belgium that focuses on traditional and alternative asset classes. Founded 2000 in Brussels Hoofdstedelijk Gewest, Belgium, it invests in early stage ventures and late stage ventures. Its portfolio companies include F2G, DoveConviene, Flayr, Plastic Logic Germany, Metara, DanioLabs, and immatics biotechnologies. As of March 2020, Merifin Capital has made 12 investments. Their most recent investment was on June 20, 2016, when F2G raised $60M. Merifin Capital has had three exits, the most notable of which include immatics biotechnologies, Cyclacel Pharmaceuticals, and DanioLabs.